I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …

Background The literature regarding clinical olfaction, olfactory loss, and olfactory
dysfunction has expanded rapidly over the past two decades, with an exponential rise in the …

Objective This update of a 2007 guideline from the American Academy of Otolaryngology—
Head and Neck Surgery Foundation provides evidence-based recommendations to manage …

The methodology for EPOS2012 has been the same as for the other two productions.
Leaders in the field were invited to critically appraise the literature and write a report on a …

Chronic rhinosinusitis (CRS) affects 12.5% of the US population. On epidemiologic grounds,
some association has been found between CRS prevalence and air pollution, active …

Rhinitis and sinusitis are among the most common medical conditions and are frequently
associated. In Western societies an estimated 10% to 25% of the population have allergic …

BACKGROUND: There is little scientific evidence to support the current practice of using oral
glucocorticosteroids and antibiotics to treat patients with chronic rhinosinusitis and nasal …

This document provides healthcare practitioners with information regarding the
management of acute rhinosinusitis (ARS) and chronic rhinosinusitis (CRS) to enable them …

Rhinosinusitis (RS) affects approximately 1 in 7 adults in the United States, and its effect on
quality of life, productivity, and finances is substantial. During the past 10 years, several …

Rhinosinusitis is one of the most commonly diagnosed diseases in the United States.
Analysis of the Centers for Disease Control and Preventionesponsored 2010 US National …